Results 71 to 80 of about 203 (90)

Farmacogenética del cáncer colorrectal en un hospital terciario de Valencia. [PDF]

open access: yesAdv Lab Med
Comes-Raga A   +4 more
europepmc   +1 more source

Farmacogenômica: oportunidades e desafios

open access: yesBrazilian Journal of Psychiatry, 2001
Licinio Julio
doaj  

<i>CYP2C9</i> Promoter Variable Number Tandem Repeat Polymorphism in a Dominican Population: Exploring Differences with Genetic Ancestry. [PDF]

open access: yesGenes (Basel)
de la Cruz CG   +6 more
europepmc   +1 more source

Progesterone promotes CXCl2-dependent vaginal neutrophil killing by activating cervical resident macrophage-neutrophil crosstalk. [PDF]

open access: yesJCI Insight
Gómez-Oro C   +12 more
europepmc   +1 more source

Dose-Limiting Toxicities and the Maximum Tolerated Dose of Irinotecan Based on <i>UGT1A1</i> Genotypes: A Systematic Review. [PDF]

open access: yesPharmaceutics
Díaz-Villamarín X   +9 more
europepmc   +1 more source

Combining BET inhibition with SMAC mimetics restricts tumor growth and triggers immune surveillance in preclinical cancer models. [PDF]

open access: yesCell Rep Med
Slavic Obradovic K   +24 more
europepmc   +1 more source

Would the combination of everolimus with endocrine-therapy help in FGFR2 positive serous endometrial cancer? [PDF]

open access: yesOncoscience, 2015
Cappelletti MR   +5 more
europepmc   +1 more source

[The Usefulness of Neuromodulators in Clinical Practice: The Gastroenterologist's Viewpoint]. [PDF]

open access: yesActa Gastroenterol Latinoam
García-Zermeño KR   +3 more
europepmc   +1 more source

Clinical, laboratory and epidemiological aspects of HPV infection in a low-income population from South Bahia, Brazil. [PDF]

open access: yesEpidemiol Infect, 2017
Gadelha SR   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy